Rocket Pharmaceuticals Inc RCKT Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	551.81M	514.76M	461.78M	598.76M	566.34M	499.44M	446.41M	393.69M
Total Current Assets	364.06M	338.03M	312.07M	446.87M	378.22M	345.16M	292.73M	241.75M
Cash and Equivalents	140.52M	64.58M	45.08M	225.66M	55.9M	35.28M	38.61M	65.6M
Total Non-Current Assets	170.09M	161.18M	137.1M	143.38M	182.77M	149.64M	149.79M	147.55M
Total Liabilities	62.12M	55.88M	58.81M	57.68M	73.77M	57.94M	61.78M	63.92M
Total Current Liabilities	39.17M	31.21M	34.35M	33.48M	48.51M	32.96M	37.59M	39.98M
Total Non-Current Liabilities	42.22M	43.97M	43.78M	43.54M	44.62M	44.35M	43.56M	43.32M
Common Equity	791k	804k	805k	901k	903k	906k	910k	911k
Retained Earnings	-713.78M	-772.11M	-837.81M	-899.71M	-959.37M	-1.02B	-1.09B	-1.16B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	129.65M	101.78M	251.31M	372.12M	590.82M	497.02M	551.81M	566.34M
Total Current Assets	128.35M	101.05M	209.09M	307.75M	487.35M	392.06M	364.06M	378.22M
Cash and Equivalents	29.8M	78.72M	111.36M	185.38M	297.1M	232.69M	140.52M	55.9M
Total Non-Current Assets	73.17M	47.76M	194.04M	307.3M	503.52M	454.72M	489.69M	492.57M
Total Liabilities	56.48M	54.01M	57.28M	64.82M	87.31M	42.3M	62.12M	73.77M
Total Current Liabilities	7.21M	4.07M	15.37M	18.31M	32.62M	22.17M	39.17M	48.51M
Total Non-Current Liabilities	98.23M	99.49M	83.35M	91.56M	108.74M	39.27M	42.22M	44.62M
Total Equity	73.17M	47.76M	194.04M	307.3M	503.52M	454.72M	489.69M	492.57M
Common Equity	270k	68k	452k	548k	610k	645k	791k	903k
Retained Earnings	-238.88M	-268.37M	-105.87M	-183.14M	-322.84M	-491.91M	-713.78M	-959.37M